Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

Hepatocyte Growth Factor (HGF, also known as Scatter Factor) is a powerful mitogen or motility factor in different cells, acting through the tyrosine kinase receptor encoded by the MET protooncogene. Endothelial cells express the MET gene and expose at the cell surface the mature protein (p190MET) made of a 50 kD (alpha) subunit disulfide linked to a 145-kD (beta) subunit. HGF binding to endothelial cells identifies two sites with different affinities. The higher affinity binding site (Kd = 0.35 nM) corresponds to the p190MET receptor. Sub- nanomolar concentrations of HGF, but not of a recombinant inactive precursor, stimulate the receptor kinase activity, cell proliferation and motility. HGF induces repairs of a wound in endothelial cell monolayer. HGF stimulates the scatter of endothelial cells grown on three-dimensional collagen gels, inducing an elongated phenotype. In the rabbit cornea, highly purified HGF promotes neovascularization at sub-nanomolar concentrations. HGF lacks activities related to hemostasis-thrombosis, inflammation and endothelial cells accessory functions. These data show that HGF is an in vivo potent angiogenic factor and in vitro induces endothelial cells to proliferate and migrate.

[1]  W. Birchmeier,et al.  A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Mantovani,et al.  Cytokine regulation of endothelial cell function , 1992, Behring Institute Mitteilungen.

[3]  E. Butcher.  Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity , 1991, Cell.

[4]  L. Orci,et al.  Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor , 1991, Cell.

[5]  L. Cantley,et al.  The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. , 1991, The Journal of biological chemistry.

[6]  E Medico,et al.  Expression of the Met/HGF receptor in normal and neoplastic human tissues. , 1991, Oncogene.

[7]  L. Naldini,et al.  Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase. , 1991, The Journal of biological chemistry.

[8]  A. Bardelli,et al.  Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. , 1991, The EMBO journal.

[9]  A. Sica,et al.  Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. , 1991, Journal of immunology.

[10]  N. Fausto.  Hepatocyte growth factor receptor and the c-met oncogene Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802?804 , 1991 .

[11]  P. Comoglio,et al.  The receptor encoded by the human C‐MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors , 1991, International journal of cancer.

[12]  M. Kuwano,et al.  Hepatocyte growth factor modulates migration and proliferation of human microvascular endothelial cells in culture. , 1991, Biochemical and biophysical research communications.

[13]  K. Matsumoto,et al.  Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. , 1991, Experimental cell research.

[14]  T. Nakamura,et al.  Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. , 1991, Journal of cell science.

[15]  W. Birchmeier,et al.  Evidence for the identity of human scatter factor and human hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Pappin,et al.  Purification and characterization of biologically active scatter factor from ras-transformed NIH 3T3 conditioned medium. , 1991, Biochemical Journal.

[17]  E. Gherardi,et al.  Hepatocyte growth factor--scatter factor: mitogen, motogen, and met. , 1991, Cancer cells.

[18]  N. Kitamura,et al.  Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes. , 1991, Journal of Clinical Investigation.

[19]  T. Nakamura,et al.  Identification and change in the receptor for hepatocyte growth factor in rat liver after partial hepatectomy or induced hepatitis. , 1991, Biochemical and biophysical research communications.

[20]  G. Michalopoulos,et al.  Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. , 1991, Oncogene.

[21]  P. Comoglio,et al.  c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. , 1991, Oncogene.

[22]  W. Birchmeier,et al.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.

[23]  L. Naldini,et al.  The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation , 1991, Molecular and cellular biology.

[24]  A. Mantovani,et al.  In vitro and in vivo activation of endothelial cells by colony-stimulating factors. , 1991, The Journal of clinical investigation.

[25]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[26]  J. Rubin,et al.  A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Michalopoulos,et al.  Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE. , 1991, Biochemical and biophysical research communications.

[28]  N. Yamamoto,et al.  Sequestration of a hepatocyte growth factor in extracellular matrix in normal adult rat liver. , 1991, Biochemical and biophysical research communications.

[29]  G. Michalopoulos,et al.  Identification and partial characterization of receptor binding sites for HGF on rat hepatocytes. , 1990, Biochemical and biophysical research communications.

[30]  J Vandekerckhove,et al.  Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells , 1990, The Journal of cell biology.

[31]  E. Gherardi,et al.  Hepatocytes and scatter factor , 1990, Nature.

[32]  L. Osborn,et al.  Leukocyte adhesion to endothelium in inflammation , 1990, Cell.

[33]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[34]  T. Nakamura,et al.  Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Cotran,et al.  Cytokines and endothelial cell biology. , 1990, Physiological reviews.

[36]  Anita B. Roberts,et al.  Peptide Growth Factors and Their Receptors I , 1990, Springer Study Edition.

[37]  G. Michalopoulos,et al.  Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Gullino,et al.  Gangliosides promote the angiogenic response. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[39]  C. Cooper,et al.  Biosynthesis of the protein encoded by the c-met proto-oncogene. , 1989, Oncogene.

[40]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[41]  W. Kueng,et al.  Quantification of cells cultured on 96-well plates. , 1989, Analytical Biochemistry.

[42]  M. Okigaki,et al.  Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. , 1989, Biochemical and biophysical research communications.

[43]  Donald E. Ingber,et al.  How does extracellular matrix control capillary morphogenesis? , 1989, Cell.

[44]  E. Gherardi,et al.  Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Rifkin,et al.  Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.

[46]  E. Wagner,et al.  Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment , 1989, Cell.

[47]  G. Michalopoulos,et al.  Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. , 1989, Cancer research.

[48]  C. Cooper,et al.  Tyrosine kinase receptor indistinguishable from the c-met protein , 1989, Nature.

[49]  B. Seed,et al.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. , 1989, Science.

[50]  V. Pathak,et al.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs , 1989, Molecular and cellular biology.

[51]  A. Mantovani,et al.  Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate , 1989, Nature.

[52]  G. Camussi,et al.  Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. , 1988, The Journal of biological chemistry.

[53]  P. Comoglio,et al.  p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line , 1988, Molecular and cellular biology.

[54]  E. A. Deakin,et al.  Characterization of the mouse met proto-oncogene. , 1988, Oncogene.

[55]  S. Hirono,et al.  Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. , 1988, The Journal of clinical investigation.

[56]  Toshikazu Nakamura,et al.  Purification and subunit structure of hepatocyte growth factor from rat platelets , 1987, FEBS letters.

[57]  Michael Stoker,et al.  Scatter factor is a fibroblast-derived modulator of epithelial cell mobility , 1987, Nature.

[58]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[59]  L. Orci,et al.  Basic fibroblast growth factor induces angiogenesis in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[60]  W. Fiers,et al.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. , 1986, Journal of immunology.

[61]  S. Schwartz,et al.  Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. , 1986, Science.

[62]  T. Nakamura,et al.  Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[63]  C. Cooper,et al.  Mechanism of met oncogene activation , 1986, Cell.

[64]  D. Stern,et al.  Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[65]  G. Michalopoulos,et al.  Control of hepatocyte replication by two serum factors. , 1984, Cancer research.

[66]  T. Nakamura,et al.  Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. , 1984, Biochemical and biophysical research communications.

[67]  R. Cotran,et al.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells , 1984, The Journal of experimental medicine.

[68]  L. Naldini,et al.  Detection of phosphotyrosine‐containing proteins in the detergent‐insoluble fraction of RSV‐transformed fibroblasts by azobenzene phosphonate antibodies. , 1984, The EMBO journal.

[69]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Sally H. Zigmond,et al.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. , 1973 .

[71]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[72]  T. Nakamura,et al.  Purification and characterization of hepatocyte growth factor from injured liver of carbon tetrachloride-treated rats. , 1991, Journal of biochemistry.

[73]  D. W. Vinter,et al.  Smooth muscle-derived factor stimulates mobility of human tumor cells. , 1990, Invasion & metastasis.

[74]  D. W. Vinter,et al.  Quantitation of cytokine-stimulated migration of endothelium and epithelium by a new assay using microcarrier beads. , 1990, Experimental cell research.

[75]  G. V. Vande Woude,et al.  Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[76]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.

[77]  A. Mantovani,et al.  Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. , 1985, The Journal of clinical investigation.